Pfäffikon (SZ) Switzerland 9th of December 2020 – Saiba Animal Health reported today that it has executed a contract with Boehringer Ingelheim.
Saiba Animal Health AG announced Wednesday the commencement of an agreement with Boehringer Ingelheim, a global leader in animal health. The new partnership will further enable a core element of Saiba’s business strategy, which is to form alliances with top-tier companies in order to advance its technology, projects and pipeline. Towards this end, the agreement announced today is the fourth with an industry leader since Saiba’s founding in 2014.
Dr Gary T. Jennings, CEO of Saiba Animal Health AG stated, “We are delighted to have signed this agreement with Boehringer, and honored to be working with such a renowned and innovative global player in the expanding and lucrative animal health sector. Boehringer Ingelheim’s expertise and strength in development and marketing makes then an ideal partner for us. Moreover, we feel that partnership with a company of such stature validates the potential of our technology to address major unmet needs in veterinary medicine”
For further information, please contact
Saiba Animal Health AG
CH-8808 Pfäffikon (SZ),
Gary Jennings, PhD CEO